Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

December 9, 2024

Study Completion Date

September 30, 2025

Conditions

Shigellosis

Interventions

BIOLOGICAL

bacteriophage

A cocktail of lytic Shigella-specific bacteriophages orally administered with sodium bicarbonate solution

OTHER

Placebo

Placebo orally administered with sodium bicarbonate solution

Trial Locations (1)

University of Maryland, Baltimore, University of Maryland School of Medicine, Center for Vaccine Development and Global Health, Baltimore

All Listed Sponsors

collaborator

University of Maryland, Baltimore

OTHER

lead

Intralytix, Inc.

INDUSTRY